Stage 1 is the earliest stage of multiple myeloma. People with stage 1 have lower levels of beta-2-microglobulin (below 3.5 milligrams per liter) and higher albumin levels (3.5 grams per deciliter ...

The first patient with relapsed/refractory acute myeloid leukemia has received KJ-C2320, an allogeneic CAR T-cell therapy ...

In February 2023, Lineage Cell Therapeutics, Inc. announced a collaboration with Eterna Therapeutics, Inc. to develop beta-2 microglobulin (B2M)-deficient iPSC lines. This partnership aims to ...